The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.
INTRODUCTION
The p53 tumor suppressor acts as a central node in cellular stress response programs induced by DNA damage and oncogene activation (Vousden and Prives, 2009 ). p53 binds DNA in a sequence-specific manner and controls the expression of target genes that mediate its diverse effects (Vousden and Prives, 2009) . p53 can limit the propagation of premalignant cells by promoting cell-cycle exit or apoptosis, though p53 has other functions that contribute to its tumor-suppressive action depending on context (Li et al., 2012) . Consequently, p53 mutations enable the unrestrained proliferation of damaged cells and thereby promote tumorigenesis in many tissue types.
Cellular senescence is another p53-dependent program that limits tumorigenesis (Collado and Serrano, 2010) . Senescence is a form of proliferative arrest that is associated with the stable repression of E2F target genes. However, senescent cells also downregulate the production of extracellular matrix (ECM) proteins, upregulate ECM-degrading enzymes, and secrete a variety of immune modulators and inflammatory cytokines (Coppé et al., 2008) , an effect that is mediated by cooperation between p53 and nuclear factor-kB (NF-kB) (Chien et al., 2011; Jing et al., 2011) . Collectively, these properties define the senescenceassociated secretory phenotype (SASP) and are associated with marked changes in protein secretion (Campisi and d'Adda di Fagagna, 2007) .
SASP factors can reinforce the senescence program and influence tissue microenvironment. Thus, key SASP factors can act in an autocrine manner to reinforce senescent growth arrest (Acosta et al., 2008; Kuilman et al., 2008) and/or provoke immune surveillance of the senescent cells, leading to their elimination (Kang et al., 2011; Krizhanovsky et al., 2008; Reimann et al., 2010; Xue et al., 2007) . In the context of certain wound-healing responses, SASP limits the extent of tissue damage and facilitates wound resolution (Kong et al., 2012; Krizhanovsky et al., 2008) . However, the impact of SASP on malignant initiation or progression is poorly understood, with studies suggesting that the program can be either pro-or antitumorigenic (Coppé et al., 2008; Kang et al., 2011; Krtolica et al., 2001; Xue et al., 2007) .
We explore the biology of a stromal-derived SASP program triggered by p53 on cancer initiation in the liver, a well-studied setting in which the microenvironment strongly influences epithelial tumorigenesis (Zhang and Friedman, 2012) . In this tissue, tumor initiation is often preceded by hepatic fibrosis resulting from liver damage produced by chronic hepatitis, alcohol, or chemical insults. Here, dying hepatocytes trigger the proliferation of hepatic stellate cells (HSCs), which accumulate in the liver and coordinate the production of ECM components that form the fibrotic scar. During chronic injury, an ongoing cycle of cell death, HSC proliferation, inflammation, and fibrosis eventually leads to organ failure through cirrhosis, which is the strongest risk factor for the emergence of hepatocellular carcinoma (HCC)-the third leading cause of cancer deaths worldwide (Bataller and Brenner, 2005) .
We previously implicated a p53-dependent senescence program as part of a tissue homeostatic mechanism that restricts the extent of fibrosis and facilitates its resolution (Krizhanovsky et al., 2008) . Specifically, we observed that, after an initial proliferative phase associated with fibrogenesis, HSCs eventually senesce. We demonstrated that this p53-mediated senescence program limits the extent of fibrosis by halting HSC proliferation through the cell-autonomous action of canonical senescence regulators and the non-cell-autonomous effects of SASP on ECM and immune surveillance. Consistent with this model, mice in which p53 was disabled specifically in HSCs displayed excessive fibrosis following chronic fibrogenic treatment. Here, we evaluate how p53 activity in HSCs influences later stages of liver disease and, ultimately, epithelial cancer development. Our results imply that p53 action can restrict cancer through non-cell-autonomous mechanisms and underscore the interplay between p53 and the tissue microenvironment.
RESULTS p53 Action in HSCs Limits Fibrosis
To investigate the impact of p53 activity in HSCs during different stages of liver damage, we conditionally deleted p53 expression in murine HSCs. Transgenic mice expressing Cre recombinase from the glial fibrillary acidic protein (GFAP) promoter (which, in the liver, is specifically expressed in HSCs) were crossed with mice harboring LoxP sites in introns 1 and 10 of the p53 gene (p53 LoxP/LoxP ) (Marino et al., 2000) . Although the GFAP promoter is primarily expressed in the adult astroglia, GFAP-Cre; p53
LoxP/LoxP conditional knockout mice show no increased evidence of brain tumors or any other disease (Marino et al., 2000) , thus allowing us dissect the role of p53 in HSCs without other confounding phenotypes. Hereafter, GFAP-Cre; p53 LoxP/LoxP conditional knockout mice are designated as HSC-p53
, whereas single-transgenic control strains are referred to as GFAP-Cre or p53-LoxP.
We subjected 8-week-old mice to a 6 week treatment with carbon tetrachloride (CCl 4 ), a well-studied fibrosis-inducing agent (Oakley et al., 2005) . Of note, cellular responses to liver damage are highly sex dependent (Naugler et al., 2007) , so in most of our analyses, only females were used for comparison. Upon liver damage, HSCs become ''activated''-i.e., they differentiate into myofibroblasts, proliferate, and produce the ECM network that constitutes the fibrotic scar (Bataller and Brenner, 2005) . As expected, the protocol produced liver fibrosis as assessed by staining with Sirius red, which directly marks the collagen within the ECM, and with hematoxylin and eosin staining (H&E), which is used to evaluate the overall liver morphology ( Figure 1A ). As quantified by laser scanning cytometry, $3% of the liver was Sirius-red positive in treated HSC-p53 D/D mice, representing an $50% increase over controls ( Figure 1B ). Similar results were observed when animals were treated with DDC (3,5-diethoxycarbonyl-1,4-dihydrocollidine), a different fibrogenic compound (Figures S1A-S1C available online), though accurate quantification was confounded owing to the appearance of red precipitates in the liver. Livers from HSC-p53 D/D transgenic mice treated with CCl 4 also showed an expansion of activated HSCs as determined by immunoblotting of a-smooth muscle actin (aSMA) in tissue extracts ( Figures 1C and 1D ) and increased production of collagen (data not shown). The above findings are consistent with those using the same protocol in which p53 was ablated in the whole animal or selectively downregulated in HSCs using transgenic RNAi (Krizhanovsky et al., 2008) , confirming a role for HSC-expressed p53 in limiting fibrosis.
p53 Activity in HSCs Restrains Cirrhosis
The excessive ECM produced by HSCs during chronic liver damage disrupts liver architecture, preceding frank cirrhosis and eventual liver failure. Cirrhosis is associated with a grossly disrupted liver architecture and parenchymal destruction and can be accompanied by the aberrant retention of fluids in the abdominal cavity (ascites), as well as pathognomonic serum levels of proteins and enzymes produced by the liver (Bataller and Figure S1 . Brenner, 2005) . To study HSC-specific functions of p53 in more advanced stages of liver damage, we challenged male and female mice by treating them twice a week with CCl 4 , a chronic regimen known to produce cirrhosis after 12 weeks of treatment (Oakley et al., 2005) . By 13 weeks, most of CCl 4 -treated HSCp53 D/D females displayed signs of overt ascites (Figure 2A ), as well as abdominal distension and weight gain when compared to similarly treated controls ( Figure 2A ). Accordingly, liver damage in HSC-p53 D/D mice was more pronounced, as indicated by decreased serum albumin and increased alanine transaminase levels measured after 13 weeks of treatment ( Figure 2A ). These pathological changes were obvious much earlier in male mice, which are more susceptible to liver damage (Naugler et al., 2007) . In fact, in HSC-p53 D/D males, retraction of the liver was identified by ultrasound examination as early as week 8 of treatment ( Figure 2B ). The excessive liver damage occurring in HSC-p53 D/D mice was associated with increased mortality. Although a few single-transgenic females exposed to CCl 4 died within 90 days (Figure 2C S2B ; p = 0.029 and p = 0.017, relative to GFAP-Cre and p53-LoxP, respectively). Histological analyses could not determine the precise origin of these tumors, and their enrichment on the liver surface suggested that they might have infiltrated from an extrahepatic site ( Figure S2A ). To determine whether these tumors may have been triggered by aberrant Cre-activation and p53 recombination, we performed PCR analysis of tumor DNA to assess the status of the conditional p53 allele. Interestingly, 60% of the tumors retained intact p53 genes ( Figures S2C and  S2D) . Thus, p53 deletion in HSCs appeared to create a liver environment that promotes tumorigenesis.
p53 Activity in HSCs Limits Epithelial Tumorigenesis
The above results prompted us to study how HSC-expressed p53 influences liver tumor development. To specifically produce tumors in the epithelial compartment, we modified our approach by combining CCl 4 fibrogenic treatment with coadministration of the carcinogen diethylnitrosamine (DEN) ( Figure 3A ). This carcinogen generates tumors in mice resembling aggressive HCC as assessed histopathologically and by gene expression profiling . To rule out the possibility that aberrant Cre activation (and hence p53 gene deletion) contributes to tumor formation in these cells, we used the compound transgenic HSC-p53 D/D ;Rosa26-LSL-LacZ, which allowed us to trace cells in which GFAP-Cre allele was active by conventional b-galactosidase (b-gal) staining. The resulting mice were treated with the regimen shown in Figure 3A , with DEN being administered 15 days after birth and CCl 4 provided for 12 weeks, starting 42 days later. Animals were sacrificed 2 days after the last CCl 4 injection (day 142), and their livers were examined for tumor incidence and histology. grade were similar to the control genotypes (data not shown). These observations imply that p53 action in HSCs can reduce HCC initiation, thereby restricting tumorigenesis in a non-cell-autonomous manner.
p53 Regulates SASP of HSCs and Genes Affecting Macrophage Function
The ability of p53 to act non-cell autonomously to suppress tumorigenesis suggests that it engages a program that influences tissue microenvironment, perhaps via its action on senescence and SASP. As a first step toward understanding mechanism, we determined how p53 action influences gene expression in HSCs. We crossed transgenic mice harboring a tetracycline-response-element (TRE)-driven shorthairpin RNA (shRNA) that efficiently represses p53 expression (TG-p53.1224) to mice expressing rtTA (a reverse tetracyclinecontrolled transactivator transgene) from the cytomegalovirus promoter ( Figure S4A ) . HSCs were purified from an adult mouse by gradient centrifugation and subjected to cell culture in the presence of doxycycline (Dox), conditions in which p53 expression was suppressed (Figure S4B) . This system enables p53 activity to be controlled in HSCs simply by the addition and removal of Dox.
In the presence of Dox, activated HSCs were GFP positive and were highly clonogenic. Upon Dox withdrawal, GFP expression was rapidly reduced, and HSCs accumulated high levels of p16, p21, and SA-b-gal (senescence-associated b-gal) activity and eventually stopped proliferating with the characteristic morphology of senescent cells ( Figures 4A, 4B , and S4C). Transcriptional profiling of proliferating versus senescent HSC preparations (n = 3 per each condition) confirmed that both sets of HSCs expressed high levels of the HSC markers aSMA ( Figure S4C ), vimentin, and vinculin (data not shown). Gene set enrichment analysis (GSEA) revealed significant similarities between p53-arrested HSCs and the ''KEGG_p53'' pathway gene set, as well as a previously identified senescence signature ( Figures S4C and S4D and Tables S1A and S1B) (Fridman and Tainsky, 2008) . Thus, Dox removal efficiently activated p53, leading to senescence.
The transcriptional profiles were subject to gene ontology (GO) analysis to systematically identify potential processes affected by p53. Genes downregulated by p53 showed a significant enrichment for the GO term ''cell cycle'' ( Figure 4D and Table S1C ) and included many E2F targets. Indeed, GSEA using a list of established E2F target genes confirmed that these are significantly underexpressed in senescent HSCs (Table  S1D) . Alternatively, genes upregulated by p53 showed enrichment for the GO terms ''extracellular matrix,'' ''proteinaceous extracellular matrix,'' and ''extracellular matrix structural constituent'' ( Figure 4D and Table S1C ). The ability of p53 to repress cell cycle and ECM genes in senescent murine HSCs is consistent with gene expression profiles from human HSCs (Krizhanovsky et al., 2008) and its ability to limit a fibrogenic response.
Genes upregulated in p53-expressing HSCs included biological processes such as cell-cycle arrest, which have previously been linked to p53 action and/or senescence ( Figure 4D and Table S1E ). Interestingly, ''Activation_of_immune_response'' and ''Activation_of_NF-kB_transcription_factor'' gene sets were enriched in senescent HSCs ( Figure S4E and Table S1F ). This same analysis identified genes associated with ''exocytosis'' and ''Vesicle_mediated_transport'' as overrepresented in senescent HSCs ( Figure S4E and Table S1F ). All of these observations suggest that p53 can directly or indirectly affect protein secretion and modulate immune signaling (Krizhanovsky et al., 2008) .
To measure protein secretion, we subjected conditioned media (CM) from p53-suppressed or p53-activated HSCs to a murine antibody array that detects secreted cytokines and chemokines ( Figures 4E, 4F , and S4F). Senescent HSCs preferentially secreted Il6, Icam1, and Ifng, whereas proliferating HSCs secreted Il3, Il4, and Il5, among other factors, in agreement with previously reported secretion profiles (Chien et al., 2011; Coppé et al., 2008; Crescenzi et al., 2011) . The most notable changes involved factors known to influence the differentiation and activity of macrophages (e.g., Il6, Ifng, and Il4 [Qian and Pollard, 2010] ), a cell type known to modulate liver fibrosis (Duffield Bars represent the average of intensity of two independent experiments (log 2 ). Factors showing 2-fold increase (blue) or decrease (red) on senescent versus proliferating HSCs are shown. In the right, representative blots from the cytokine array (F). ES, enrichment score; NES, normalized enrichment score; S, senescent; P, proliferating. See also Figure S4 and Table S1 . et al., 2005) . Of note, the preferential secretion of IL6 and IFNg was confirmed in senescent human HSCs ( Figures S4G  and S4H ), highlighting the relevance of these findings to the human setting.
p53 Signaling through SASP Influences Macrophage Polarization The data described above suggest that the SASP program triggered by p53 might influence macrophage function and/or polarization. Macrophages are myeloid cells that function in innate immunity by phagocytizing cellular debris and pathogens and stimulating the adaptive immune response (Biswas and Mantovani, 2010; Qian and Pollard, 2010) . In cancer, these subclasses can have different effects on tumorigenesis and antitumor immunity. In general, ''classically activated'' M1 macrophages have natural roles in pathogen defense and display antitumor activity, whereas ''alternatively activated'' M2 macrophages can promote angiogenesis and tissue remodeling, thereby supporting tumor progression and metastasis. Ifng favors M1 polarization, whereas Il4 and Il13 trigger M2 polarization. These macrophage subclasses can be distinguished by the differential expression of gene markers: M1 macrophages express higher levels of inflammatory and antiangiogenic cytokines such as Il1b, whereas M2 macrophages express arginase-1 (Arg1), mannose receptor-1 (Mrc1), and macrophage scavenger receptor 1 (Msr1) (Movahedi et al., 2010).
We next determined how factors secreted from proliferating or senescent HSCs affected macrophage polarization. As damaged livers are composed of resident (Kupffer cells, KCs) and infiltrating macrophages (bone-marrow-derived macrophages, BMDMs), we studied the effects of HSCs on both macrophage populations. Two genes associated with M2 phenotype, Mrc1 and Msr1, were upregulated in macrophages incubated with CM from proliferating HSCs compared to macrophages exposed to CM from senescent HSCs ( Figures  5A, 5B , S5A, and S5B). Conversely, when macrophages were exposed to CM from senescent HSCs, a significant increase in the M1-marker Il1b was observed ( Figures 5A and 5B) . Thus, p53 activation in HSCs shifts their secretory profile from supporting M2 to M1 polarization. Such changes might be important at different stages of the fibrogenic response but have the net effect of promoting the tumor-inhibitory macrophage subtypes when p53 is intact.
p53-Activated M1-like Macrophages Eliminate Senescent Cells
To evaluate the effects of p53 on ''HSC-macrophage'' interactions, we cocultured either resident (KC) or infiltrating (BMDM) macrophages with proliferating or senescent HSCs for 24-48 hr and examined their proliferation and survival by cell quantification and time-lapse video microscopy. Although the presence of macrophages (BMDMs and KCs) had little effect on the accumulation of proliferating HSCs, they showed a marked BMDM, bone-marrow-derived macrophages; KCs, Kupffer cells; CM, conditioned media; Ren, renilla; S, senescent; P, proliferating. See also Figure S5 and Movies S1, S2, S3, and S4. ability to eliminate senescent HSCs ( Figures 5C-5E and Movies S1, S2, S3, and S4). Similarly, BMDM were more effective at targeting primary p53 +/+ HSCs, which senesce in culture, than their p53 À/À counterparts, confirming that p53-mediated senescence stimulates HSC elimination by macrophages ( Figures  S5C-S5E ). Additionally, natural killer (NK) cells preferentially target senescent human (Chien et al., 2011; Krizhanovsky et al., 2008) and murine HSCs ( Figure S5F ), implying that p53 action in senescent cells triggers altered surveillance by multiple immune cell types. If p53 action in HSCs contributes to an antitumor microenvironment through its impact on macrophage polarization, we hypothesized that ''HSC-macrophage'' interactions might alter the proliferation or survival of premalignant cells. To test this, we exploited two premalignant hepatoblast progenitor lines previously used in our laboratory to identify new tumor suppressor genes in HCC . These cells were cocultured with BMDMs, incubated with CM from either growing or senescent HSCs, and quantified 48 hr later. The combination of BMDMs with CM from proliferating HSCs enhanced proliferation of premalignant cells when compared to BMDMs with CM from senescent HSCs or BMDMs with control media (Figures 5F  and 5G ). This outcome could not be explained by the individual or the additive effects of CM from proliferating HSCs or BMDMs alone on premalignant cell proliferation but rather is explained by the significant interaction between both parameters (interaction p value: p = 0.0470 [ Figure 5F ] and p = 0.0027 [Figure 5G] ). Hence, in this assay, p53 action and senescence in HSCs reduces their ability to stimulate a proproliferative microenvironment.
p53 and NF-kB Cooperate to Induce SASP and Influence Macrophage Function
To further understand how p53 influences the tissue microenvironment, we studied the regulation of SASP genes in HSCs. Whereas some of these genes are direct p53 targets (e.g., Icam1), others have not been directly linked to p53. We and others have identified a crucial role for NF-kB in the control of SASP and have shown that p53 cooperates with NF-kB to trigger senescence (Acosta et al., 2008; Chien et al., 2011; Jing et al., 2011) . Accordingly, several factors selectively secreted by senescent cells-Il6, Icam1, and Ifng-are known NF-kB targets (Chien et al., 2011; Crescenzi et al., 2011) , and GSEA confirmed that NF-kB signaling was highly upregulated in senescent HSCs ( Figure 6A ). As has been observed in other contexts (Ryan et al., 2000) , p53 triggered NF-kB activation as assessed by the nuclear accumulation of the NF-kB subunit p65 ( Figures 6B  and S6A ). How this occurs in HSCs remains to be determined, though we note that several genes upregulated in senescent HSCs (e.g., Eda2r or Pycard) are known NF-kB activators and either established p53 targets (Ohtsuka et al., 2004; Tanikawa et al., 2009) or (e.g., Tnf, Camk2a, Card11, and Ikbkb) harbored consensus p53-binding motifs ( Figures S6B and S6C and Table S1G ).
To further explore the role of NF-kB in controlling SASP, we determined how suppression of the essential NF-kB component p65
RelA affected expression of SASP factors and the targeting of senescent HSCs by BMDMs. shRNAs targeting p65 were cloned into the retroviral vector LMN ( Figure S6D ), and a Renilla luciferase shRNA was used as a neutral control. Upon p53 activation, cells expressing p65 shRNAs showed reduced Table S1. expression and secretion of Icam1 and Il6 ( Figures 6C, 6D , and S6E) compared to cells expressing the control shRNA. p65 suppression also reduced the abundance of Ifng mRNA, though the effect of this treatment on Ifng secretion was modest ( Figures  6C, 6D , and S6E). Accordingly, p65 knockdown had no effect on the viability of proliferating HSCs that were cocultured with BMDMs (data not shown) but rescued the cytotoxic effect of BMDMs on senescent HSCs ( Figure 6E ). Similar results were obtained when using shRNAs against the NF-kB targets Il6, Icam1, or Ifng ( Figures 6F and S6F) , indicating that the ability of macrophages to target senescent HSCs is a direct SASP effect and not merely a consequence of cell-cycle arrest. These results support the antitumorigenic role of NF-kB in senescent cells (Chien et al., 2011; Jing et al., 2011) and highlight the cooperation between NF-kB and p53 in executing the senescence program.
p53 Activity in HSCs Promotes an Antitumor Microenvironment
The ability of p53 to influence macrophage polarization raised the possibility that p53 status in HSCs might influence the composition of macrophage subpopulations in damaged livers. To examine this, we used fluorescence-activated cell sorting (Figures 7A and S7A ; p = 0.002 and p = 0.002, respectively). Using a quantitative RT-PCR assay of macrophage polarization markers to assess the relative abundance of macrophage subtypes in these sorted populations, we observed that those macrophages present in the control GFAP-Cre and p53-loxP livers showed higher expression levels of the M1-marker Il1b ( Figure 7B ; p = 0.001 and p = 0.043, respectively), whereas HSC-p53 D/D livers were enriched for the M2-marker Mrc1 ( Figure 7C ; p = 0.012 and p = 0.048, respectively). These results were confirmed by directly analyzing liver sections using immunofluorescence with antibodies recognizing different macrophage subpopulations ( Figures 7D, 7E, S7B , and S7C). The percentage of cells expressing the general macrophage markers Cd11b or Iba1 was reduced in HSC-p53 D/D livers ( Figure 7F ; p = 0.004 and p = 0.027 relative to GFAP-Cre and p53-LoxP, respectively). More than 50% of Cd11b + macrophages in the GFAP-Cre and p53-LoxP mice were also positive for the M1-marker Il1b, whereas only 25% of macrophages present in HSC-p53 D/D livers were Il1b positive ( Figures 7D, 7G , and S7B; p = 0.017 and p = 0.014, respectively). By contrast, more than 35% of the macrophages present in HSC-p53 D/D livers expressed the M2-marker Mrc1, compared to only 5%-15% of these cells in GFAP-Cre and p53-LoxP livers ( Figures 7E, 7H , and S7C; p = 0.0423 and p = 0.0012 when compared to GFAP-Cre and p53-LoxP, respectively). Still, not all macrophage populations could be identified using these markers, suggesting that yet other macrophage subclasses might be present in damaged livers (Ramachandran et al., 2012) . Regardless, p53 action in HSCs can trigger a quantitative and qualitative enrichment of antitumor M1 macrophages in damaged livers, which could, in part, explain the non-cell-autonomous tumor-suppressive effects of p53.
DISCUSSION
The mechanisms that link chronic inflammatory responses to tumorigenesis remain a subject of intense investigation, underscoring the need to better understand complex functional interactions that occur between different cell types in tissues.
Following chemical injury to the liver, quiescent HSCs, which are of mesenchymal origin, enter the cell cycle, differentiate, and sustain a chronic inflammatory response accompanied by fibrosis (Zhang and Friedman, 2012) . In the face of continued stress, a cycle of persistent injury, hepatocyte death, and further HSC expansion can induce cirrhosis and generate a microenvironmental milieu that provides fertile ground for HCC formation. Although proliferating HSCs initially contribute to the inflammatory response, their eventual p53-dependent senescence restrains fibrosis, organ failure, and hepatic tumorigenesis. Aberrant activation of Cre in hepatocytes cannot explain the increased propensity of HSC-p53 D/D mice to epithelial tumor development because the HCCs arising in Cre-expressing mice showed no evidence of recombination at the p53 locus. Although Cre-activatable lacZ reporter expression was detected in fibrotic areas of livers derived from tumor-bearing mice, none of the epithelial tumors were LacZ positive. Hence, p53 can act to suppress tissue damage and ultimately tumorigenesis in a non-cell-autonomous manner. These results are consistent with the observation that MCF7 breast cancer cells produce more tumors when injected subcutaneously into p53 null mice compared to wild-type controls (Kiaris et al., 2005) and are reminiscent of studies supporting a non-cell-autonomous role for Pten in suppressing breast cancer development in transgenic mice (Trimboli et al., 2009) . Nonetheless, the Cre transgene alone may impact tumorigenesis in different ways. Hence, in some experiments, we noted differences in the behavior of our GFAP-Cre and p53-LoxP control strains (e.g., see Figures 1C, 1D , and 7A-7C). This effect was most notable in male mice, which are substantially more tumor prone than females (Naugler et al., 2007) , and GFAP-Cre mice showed a significant decrease in tumors compared to p53-loxP animals, confounding comparisons between tumors in this gender (data not shown). Though the basis for the male bias remains unclear, we suspect that some form of Cre-mediated damage impacts the proliferation of HSCs as has been seen in some other settings (Forni et al., 2006) . Mice harboring Cre transgenes capable of transient Cre expression (e.g., Cre-ER) might substantially reduce this effect and improve the robustness of the model. Although p53 activity in HSCs can suppress HCC, it remains unclear whether or not mutational disruption of this program is relevant during the natural HCC progression. In principle, the high rate of cell turnover in damaged livers could lead to the selection of p53 mutant HSCs, though currently there is no indication that p53 mutations are present in cells associated with the fibrotic lesions adjacent to liver tumors. However, in other contexts, p53 mutations have been observed in stromal cells in both mice and humans (Hill et al., 2005; Kurose et al., 2002) , suggesting that such a possibility cannot be excluded. Regardless, the fact that a non-cell-autonomous stromal program can suppress organ damage and epithelial cell transformation provides a new avenue for exploiting knowledge of the p53 network in controlling ''fibrosis-cirrhosis-carcinoma'' progression.
Our data imply that p53 acts non-cell autonomously to promote an antitumorigenic tissue microenvironment. Engagement of p53 in activated murine HSCs triggers an antiproliferative program that manifests the features of senescence observed in other cell types; these features include global changes in the expression of cell-cycle regulators, SASP, and production of immune modulators that were previously linked to fibrosis resolution (Krizhanovsky et al., 2008) . Of note, whereas others reported a general suppression of the secretory phenotype by p53 in senescent fibroblasts (Coppé et al., 2008) , we observed decisively qualitative effects in HSCs, which included a significant switch in the cytokines produced by senescent versus proliferating cells.
The most prominent effects observed involved factors that influence macrophage biology. Indeed, the senescent state triggered by p53 caused a significant increase in the secretion of factors known to promote M1 polarization, which is characterized by Il1b expression and an increased propensity for cell killing and phagocytosis (Biswas and Mantovani, 2010) . By marked contrast, p53 suppressed the secretion of factors associated with M2 polarization. Accordingly, CM from p53-expressing HSCs promoted M1 polarization of macrophages, which then acquired the ability to target senescent HSCs. Conversely, CM from proliferating HSCs with suppressed p53 activity stimulated M2 polarization of macrophages, which were unable to target HSCs but could stimulate the proliferation of premalignant hepatoblasts.
The action of p53 in stimulating an antitumor microenvironment is likely to involve both direct and indirect mechanisms. On one hand, several immune-modulatory factors upregulated in HSCs undergoing senescence are direct p53 transcriptional targets. However, p53 also has a complex but well-established role in coordinating gene expression together with NF-kB, an immune modulating transcription factor. The impact of this intersection is context dependent, with some studies suggesting that NF-kB can antagonize p53 function, whereas others imply that it can complement certain p53 effects. During senescence, p53 and NF-kB cooperate in the execution of the program (Chien et al., 2011; Jing et al., 2011) , and, as shown here, this interplay influences macrophage polarization and the subsequent targeting of senescent cells. Precisely how this occurs remains to be determined and likely involves a direct effect of p53 on the transcription of NF-kB-activating factors as well as unidentified indirect effects.
Beyond its effects on macrophages, p53 signaling likely influences the microenvironment in additional ways. For example, cells triggered to senesce by p53 can recruit NK cells and cytotoxic T lymphocytes into inflammatory sites enhancing immune surveillance and can limit the production of new blood vessels through the induction of antiangiogenic molecules (Dameron et al., 1994; Kang et al., 2011; Krizhanovsky et al., 2008) . In promoting these processes, p53 acts in a quantitative way to augment recruitment of immune cells or tumor inhibitory factors. By contrast, the effects of p53-driven SASP on macrophage polarization are unique in that they qualitatively alter macrophage function, an effect that can be observed in damaged livers in vivo.
Our studies support a model whereby normal p53 activity in HSCs acts to limit the extent of liver damage and to help maintain organ integrity through its impact on SASP. Among the many factors that contribute to this effect, macrophages have long been considered to be crucial for the formation of the fibrotic scar and, paradoxically, for the resolution of fibrosis (Duffield et al., 2005; Ramachandran et al., 2012 ). An intriguing possibility is that the differential effect of proliferating and senescent HSCs on macrophage polarization underlies their opposing role in liver damage responses. In this scenario, liver damage activates HSC proliferation, which promotes the recruitment and M2 polarization of macrophages that stimulate fibrosis as part of the tissue-remodeling and proangiogenic response that maintains organ integrity. Subsequently, p53 activation and senescence in HSCs could favor M1 polarization of macrophages that counteracts these effects by promoting an antifibrogenic environment and elimination of accumulated HSCs. In the presence of chronic liver damage, proliferating HSCs that fail to activate p53 would continue to accumulate, biasing macrophage populations in the liver to the tumorigenic M2 subtype that can also enhance the proliferation of premalignant cells. Consistent with this view, M2 macrophages accumulate in patients with chronic liver disease (Zimmermann et al., 2011) , whereas the accumulation of M1 macrophages has been linked to reduced fibrosis (Hesse et al., 2000) .
We propose that the non-cell-autonomous action of p53 in HCC is an inadvertent consequence of its action in this natural wound healing response. Thus, the same factors that influence wound resolution create a microenvironment that resists epithelial cell transformation through a variety of mechanisms including, as shown here, an increase in production of antitumor modulators and cell types. However, upon chronic damage, an inherently protumorigenic milieu created by M2 macrophages and by other factors affected by proliferating HSCs predominates and creates an environment prone to epithelial cell transformation. Although further studies are needed, the fact that p53 can communicate a tumor-suppressive program through soluble components that modify the tissue microenvironment offers insights into this well-characterized tumor-suppressor network and provides optimism that these effects might eventually be phenocopied therapeutically for improving liver function and reducing liver cancer incidence.
EXPERIMENTAL PROCEDURES Animals and Housing
Animal work was conducted in accordance with protocols approved by the Institutional Animal Care and Use Committees at CSHL and MSKCC. Mice were maintained under specific pathogen-free conditions, and food and water were provided ad libitum. Animal treatment details are in Extended Experimental Procedures.
Histological Analysis
Paraffin-embedded tissue sections were stained with H&E for routine examination, Sirius red for visualization of fibrotic deposition, and Gordon and Sweet's for Reticulin. At least three whole sections from each animal were scanned with Laser Scanner Cytometry (CompuCyte; Aperio) for fibrosis analysis. The images were quantified using NIH ImageJ software (http://rsb.info.nih.gov/ij/). The amount of fibrotic tissue was calculated relative to the total analyzed liver area. Detection of transgenic-b-gal activity was performed as previously described at pH = 7.4 (Krizhanovsky et al., 2008) .
Tissue Culture HSCs were grown in DMEM supplemented with 10% FBS, 1% glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, and 1 mg/ml doxycycline (Dox). Senescence was induced by withdrawing Dox, replicative exhaustion, or by adding etoposide (100 mM, Sigma). Detection of senescence-associated b-gal activity was performed as previously described at pH = 5.5 (Krizhanovsky et al., 2008) . Cell isolation and cytotoxicity experiments are described in Extended Experimental Procedures.
Quantitative RT-PCR and Expression Array Analysis
Murine HSCs, primary BMDMs, or sorted macrophages were freshly homogenized in Trizol (GIBCO). RNA isolation, cDNA synthesis, and quantitative RT-PCRs were performed as previously described (Xue et al., 2007) . Microarray experiments were performed on Mouse Genome 430A 2.0 Arrays (Affymetrix) at MSKCC Genomics Core. GSEA analysis was performed using GSEA v2.07 software with 1,000 phenotype permutations. For GO term analysis, DAVID Bioinformatics Resources 6.7 was utilized at http://david.abcc. ncifcrf.gov/home.jsp. Gene sets used in this study, technical details, and the list of Taqman probes are included in Table S1 and Extended Experimental Procedures.
Immunoblotting
Liver tissues were lysed in Laemmli buffer using a tissue homogenizer. Cellular lysates from HSCs or macrophages were also prepared by lysing with Laemmli buffer. Equal amounts of protein were separated on 12% SDS-polyacrylamide gels and transferred to PVDF membranes. The abundance of b-actin was monitored to ensure equal loading. Images were analyzed using the NIH Image J software. Immunofluorescence staining was performed as previously described (Chien et al., 2011) . Alexa Fluor conjugates (Molecular Probes) were used as the secondary antibodies, and DNA was visualized with 49-6-diamidino-2-phenylindole (DAPI; Vector Laboratories). The details of fluorescence quantification and the list of antibodies can be found in Extended Experimental Procedures.
Sorting of Macrophages
Livers from CCl 4 -treated animals were digested with dispase (0.2%, GIBCO) in HBSS during 30 min at 37 C and then filtered through a 100 mm mesh filter.
Red blood cells were eliminated by washing with 13 RBC Lysis Buffer (eBioscience). Samples were then washed with FACS buffer (1% BSA in PBS), followed by Fc block for 15 min at 4 C and antibody labeling for 15 min at 4 C. Antibodies used for cell type identification were CD45-APC
(1:500; BD Biosciences PharMingen), Gr1-FITC (1:500; BD Biosciences PharMingen), and Cd11b-PE (1:500; BD Biosciences PharMingen). FACS buffer with DAPI (Invitrogen) was then added to each sample, followed by acquisition and sorting on an Aria1 sorter (BD).
Statistics
Statistical significance was calculated by two-tailed Student's t test. Log rank test was used to determine overall and pairwise significance for survival curves. Interaction between CM and BMDM effects was calculated with two-way ANOVA. Prism 5 Software was used for the generation of the survival graphs and statistical analyses. Significance values are *p < 0.05, **p < 0.01, and ***p < 0.001. Ns stands for nonsignificant (p > 0.05).
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All raw microarray data files are available in the GEO database (GSE39469). 
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